Kaia Agarwal is an independent regulatory consultant working with PharmApprove, with over 30 years of global leadership experience in the pharmaceutical and biotechnology industry, with strategic regulatory expertise across CMC and Clinical Development. Kaia has extensive experience leading teams in the development and registration of several small molecules, vaccines and biologic products across all major therapeutic areas and regions, including Cardiovascular, Endocrine, CNS, Pain, Immunology, Oncology, Antivirals, and Vaccines. She has led teams preparing for global filings, global agency meetings and has supported over 16 advisory committee meetings. She was most recently the VP and Global Head Regulatory Affairs for Novartis Vaccines.